Justin J. Leitenberger, M.D.

  • Associate Professor of Dermatology, School of Medicine


Dr. Leitenberger specializes in all aspects of surgical dermatology with special interests in Mohs micrographic surgery, reconstructive surgery, and management of skin cancer in high-risk patients.  He is an associate professor of dermatology and surgery, a co-director of Dermatologic Surgery, and a co-director of the High-Risk Non-Melanoma Skin Cancer ClinicDr. Justin Leitenberger is double board certified in Dermatology and Mohs micrographic surgery.

Dr. Leitenberger also performs laser and cosmetic surgery, including minimally-invasive laser skin resurfacing as well as injectable fillers and neurotoxins.  He enjoys supporting medical professional education and regularly instructs a surgical dermatology fellow, residents in dermatology and other surgical subspecialties, and rotating medical students.

Dr. Leitenberger received his medical degree from the University of Texas at Houston, during which time he received the Doris Duke Clinical Research Fellowship Award at the University of Texas Southwestern Medical Center at Dallas. He completed both his dermatology residency and surgical fellowship subspecialty training at OHSU. Additionally, he  has published in several peer-reviewed journals and has spoken at national conferences.  Outside of work, Dr. Leitenberger enjoys spending time with his wife and two young boys, hiking, biking, skiing, and playing golf and tennis.

Education and training

    • B.S., 2003, University of Notre Dame
    • M.D., 2008, University of Texas McGovern Medical School at Houston
  • Residency

    • Dermatology, Oregon Health & Science University, Portland, OR
  • Fellowship

    • Dermatologic surgery, Oregon Health & Science University, Portland, OR
  • Certifications

    • American Board of Dermatology, Dermatology
    • American Board of Dermatology, Mohs micrographic surgery

Memberships and associations:

  • American Academy of Dermatology
  • American Society for Dermatologic Surgery
  • Dermatology Foundation
  • American College of Mohs Surgery
  • Oregon Medical Association
  • Oregon Dermatology Society


Elsevier pure profile

Selected publications

  • Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression. Taniguchi S, Elhance A, Van Duzer A, Kumar S, Leitenberger JJ, Oshimori N. Science. 2020 Jul 17;369(6501):eaay1813. doi: 10.1126/science.aay1813. PMID: 32675345.
  • Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee. Leitenberger JJ, Rogers H, Chapman JC, Maher IA, Fox MC, Harmon CB, Bailey EC, Odland P, Wysong A, Johnson T, Wisco OJ. J Am Acad Dermatol. 2016 Nov;75(5):1022-1031. doi: 10.1016/j.jaad.2016.06.047. Epub 2016 Aug 18. PMID: 27546292.
  • Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborative (ITSCC). Zwald F, Leitenberger J, Zeitouni N, Soon S, Brewer J, Arron S, Bordeaux J, Chung C, Abdelmalek M, Billingsley E, Vidimos A, Stasko T. Am J Transplant. 2016 Feb;16(2):407-13. doi: 10.1111/ajt.13593. Epub 2
  • Invasive Melanoma and Melanoma in Situ Treated With Modified Mohs Micrographic Surgery With En Face Permanent Sectioning: A 10-Year Retrospective Review. Heath M, Woody M, Leitenberger J, Latour E, Bar A. Dermatol Surg. 2020 Aug;46(8):1004-1013. doi: 10.1097/DSS.0000000000002246. PMID: 31714384.
  • Identifying and defining complications of dermatologic surgery to be tracked in the American College of Mohs Surgery (ACMS) Registry. Council ML, Alam M, Gloster HM Jr, Bordeaux JS, Carroll BT, Leitenberger JJ, Wisco OJ, Maher IA. J Am Acad Dermatol. 2016 Apr;74(4):739-45. doi: 10.1016/j.jaad.2015.10.023. Epub 2015 Nov 24. PMID: 26621700.
  • Opioid Prescribing Recommendations After Mohs Micrographic Surgery and Reconstruction: A Delphi Consensus.Donigan JM, Srivastava D, Maher I, Abdelmalek M, Bar AA, Blalock TW, Bordeaux JS, Brodland DG, Carroll BT, Council ML, Duffy K, Fathi R, Golda N, Johnson-Jahangir H, Konda S, Leitenberger JJ, Moye M, Nelson JL, Patel VA, Shaffer JJ, Soltani-Arabshahi R, Tristani-Firouzi P, Tschetter AJ, Nijhawan RI. Dermatol Surg. 2020 Aug 3. doi: 10.1097/DSS.0000000000002551.
  • Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States. Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, Cannon J, Chen A, Cheng JY, Chiesa-Fuxench Z, Colegio OR, Curiel-Lewandrowski C, Del Guzzo CA, Disse M, Dowd M, Eilers R Jr, Ortiz AE, Morris C, Golden SK, Graves MS, Griffin JR, Hopkins RS, Huang CC, Bae GH, Jambusaria A, Jennings TA, Jiang SI, Karia PS, Khetarpal S, Kim C, Klintmalm
  • Aggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor Ruxolitinib. Blechman AB, Cabell CE, Weinberger CH, Duckworth A, Leitenberger JJ, Zwald FO, Russell MA. J Drugs Dermatol. 2017 May 1;16(5):508-511. PMID: 28628689.
  • Reconstruction After Full-Thickness Loss of the Antihelix, Scapha, and Triangular Fossa. Leitenberger JJ, Golden SK. Dermatol Surg. 2016 Jul;42(7):893-6. doi: 10.1097/DSS.0000000000000664. PMID: 26885837.
  • Sebaceous carcinoma: evidence-based clinical practice guidelines. Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, et al. Lancet Oncol. 2019 Dec;20(12):e699-e714. doi: 10.1016/S1470-2045(19)30673-4. PMID: 3


  • {{ pub.journalAssociation.journal.name.text[0].value }}